51.83
前日終値:
$52.17
開ける:
$52.01
24時間の取引高:
247.80K
Relative Volume:
0.60
時価総額:
$2.57B
収益:
$379.25M
当期純損益:
$-77.34M
株価収益率:
-32.15
EPS:
-1.6122
ネットキャッシュフロー:
$-27.87M
1週間 パフォーマンス:
-0.19%
1か月 パフォーマンス:
+3.39%
6か月 パフォーマンス:
+9.05%
1年 パフォーマンス:
+28.39%
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
名前
Mirum Pharmaceuticals Inc
セクター
電話
650-667-4085
住所
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MIRM
Mirum Pharmaceuticals Inc
|
51.83 | 2.58B | 379.25M | -77.34M | -27.87M | -1.6122 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-05-19 | 再開されました | H.C. Wainwright | Buy |
2024-04-17 | 開始されました | Stifel | Buy |
2023-12-18 | 繰り返されました | H.C. Wainwright | Buy |
2023-11-20 | 再開されました | JP Morgan | Overweight |
2023-11-13 | 開始されました | Morgan Stanley | Overweight |
2023-10-24 | 開始されました | Cantor Fitzgerald | Overweight |
2023-10-17 | 再開されました | Evercore ISI | Outperform |
2023-09-20 | 開始されました | JMP Securities | Mkt Outperform |
2022-09-01 | 開始されました | Citigroup | Buy |
2021-09-20 | 開始されました | JP Morgan | Overweight |
2020-08-07 | アップグレード | Raymond James | Outperform → Strong Buy |
2020-08-03 | 開始されました | H.C. Wainwright | Buy |
2020-07-31 | 開始されました | Piper Sandler | Overweight |
2020-06-25 | 開始されました | Robert W. Baird | Outperform |
2019-08-12 | 開始されました | Citigroup | Buy |
2019-08-12 | 開始されました | Evercore ISI | Outperform |
2019-08-12 | 開始されました | Guggenheim | Buy |
2019-08-12 | 開始されました | ROTH Capital | Buy |
2019-08-12 | 開始されました | Raymond James | Outperform |
すべてを表示
Mirum Pharmaceuticals Inc (MIRM) 最新ニュース
What analysts say about Mirum Pharmaceuticals Inc. stockExceptional market positioning - PrintWeekIndia
Is Mirum Pharmaceuticals Inc. stock a growth or value playAccelerated profit realization - jammulinksnews.com
Mirum Pharmaceuticals Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional
What drives Mirum Pharmaceuticals Inc. stock priceConsistently profitable trades - jammulinksnews.com
Is Mirum Pharmaceuticals Inc. a good long term investmentExceptional earning trajectories - jammulinksnews.com
Mirum Gains 35% in 3 Months: How Should You Play the Stock? - MSN
Purpose, not just product: What sets Mirum apart - Endpoints News
Bank of New York Mellon Corp Acquires 122,402 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Q1 2025 Earnings Call Transcript - MSN
Mirum Pharma’s Rare Disease Bets Are Paying Off For Investors - Finimize
Teacher Retirement System of Texas Sells 925 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Mirum Pharmaceuticals Advances Phase 3 Study on Maralixibat for Cholestatic Pruritus - TipRanks
When the Price of (MIRM) Talks, People Listen - news.stocktradersdaily.com
How Mirum Pharmaceuticals Inc. stock performs during market volatilityEntry Level Low Risk Picks - Newser
What makes Mirum Pharmaceuticals Inc. stock price move sharplyFree Access to Investment Community - Newser
Why Mirum Pharmaceuticals Inc. stock attracts strong analyst attentionMarket Beating Strategy - Newser
Mirum Pharmaceuticals stock hits all-time high at $54.46 - Investing.com Australia
Mirum Hits All-Time HighIs There More Upside Ahead? - RTTNews
Mirum Pharmaceuticals stock hits all-time high at $54.46 By Investing.com - Investing.com South Africa
Mirum Pharmaceuticals price target raised to $76 from $68 at Evercore ISI - MSN
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
KBC Group NV Makes New Investment in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) - Defense World
Top Analyst Ratings From Last Week - The Globe and Mail
Mirum Pharmaceuticals Inc (MIRM) 財務データ
収益
当期純利益
現金流量
EPS
Mirum Pharmaceuticals Inc (MIRM) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Howe Jolanda | SVP, GLOBAL CONTROLLER |
Jul 03 '25 |
Sale |
49.08 |
477 |
23,411 |
2,426 |
大文字化:
|
ボリューム (24 時間):